Form 485APOS - Post-effective amendment [Rule 485(a)]:
SEC Accession No. 0000891092-14-006682
Filing Date
2014-09-03
Accepted
2014-09-03 17:26:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS e60348_485apos.htm 485APOS 565477
2 FORM OF INVESTMENT SUB-ADVISORY AGREEMENT e60348ex_d2.htm EX-99.(D)(2) 77895
4 GRAPHIC image_001.jpg GRAPHIC 160
  Complete submission text file 0000891092-14-006682.txt   646063

Series and Classes/Contracts Information:

New
  Status Name Ticker Symbol
CIK 0001559109      
Series S000047353 new BioShares Biotechnology Clinical Trials Fund
Class/Contract C000148681 BioShares Biotechnology Clinical Trials Fund
  Status Name Ticker Symbol
CIK 0001559109      
Series S000047354 new BioShares Biotechnology Products Fund
Class/Contract C000148682 BioShares Biotechnology Products Fund
Mailing Address 501 MADISON AVENUE SUITE 501 NEW YORK NY 10022
Business Address 501 MADISON AVENUE SUITE 501 NEW YORK NY 10022 347-903-7347
ETFis Series Trust I (Filer) CIK: 0001559109 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 485APOS | Act: 33 | File No.: 333-187668 | Film No.: 141081303

Mailing Address 501 MADISON AVENUE SUITE 501 NEW YORK NY 10022
Business Address 501 MADISON AVENUE SUITE 501 NEW YORK NY 10022 347-903-7347
ETFis Series Trust I (Filer) CIK: 0001559109 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 485APOS | Act: 40 | File No.: 811-22819 | Film No.: 141081304